Whalesbook
Cosmo Pharmaceuticals and Glenmark Pharmaceuticals announced that the European Commission has granted marketing authorisation for Winlevi (clascoterone 10 mg/g cream). This approval allows for the commercial launch of the acne treatment across 15 European countries, following a positive opinion from the European Medicines Agency. Winlevi is indicated for acne vulgaris in adults and adolescents aged 12 and older.